logo

For the Inventor, By the Inventor

San Clemente, CA, United States of America

Gerald Woodrow DeVries

This inventor holds 15 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignees: Allergan, Inc., Aiviva Biopharma, Inc., Other. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerald Woodrow DeVries. Retrieved from https://idiyas.com/inventor/gerald-woodrow-devries

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 73.3

 

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 40(Granted Patents)


Location History:

  • Laguna Hills, CA (US) (2021)
  • San Clemente, CA (US) (2010 - 2022)

Company Filing History:

goldMedal10 out of 2,287 
 
Allergan, Inc.
 patents
silverMedal5 out of 7 
 
Aiviva Biopharma, Inc.
 patents
bronzeMedal1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 12502391 - Multi-kinase inhibitors of VEGF and TGF beta and uses thereof (2025-12-23),
2. 12138252 - Multikinase inhibitors of VEGF and TGF beta and uses thereof (2024-11-12),
3. 11400089 - Multikinase inhibitors and uses in reproductive and digestive tract fibrosis (2022-08-02),
4. 11376252 - Multikinase inhibitors and uses in prostatic hyperplasia and urinary track diseases (2022-07-05),
5. 11278546 - Multikinase inhibitors and uses in ocular fibrosis (2022-03-22),
6. 11078262 - High viscosity macromolecular compositions for treating ocular conditions (2021-08-03),
7. 10881608 - Biodegradable intravitreal tyrosine kinase implants (2021-01-05),
8. 10076492 - Biodegradable intravitreal tyrosine kinase implants (2018-09-18),
9. 9233070 - Biodegradable intravitreal tyrosine kinase implants (2016-01-12),
10. 8968766 - Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods (2015-03-03),
11. 8591885 - Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems (2013-11-26),
12. 8455656 - Kinase inhibitors (2013-06-04),
13. 8383825 - Kinase inhibitors (2013-02-26),
14. 8143410 - Kinase inhibitors (2012-03-27),
15. 7749530 - Kinase inhibitors (2010-07-06),

Title: The Innovative Journey of Gerald Woodrow DeVries

Introduction: Gerald Woodrow DeVries, a distinguished inventor hailing from San Clemente, CA, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: DeVries holds several patents in various fields, including renewable energy, artificial intelligence, and medical devices, showcasing his versatility and ingenuity in the realm of invention.

Career Highlights: With a career spanning over two decades, DeVries has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His commitment to pushing the boundaries of technology has led to the creation of several revolutionary products that have had a lasting impact on society.

Collaborations: Throughout his career, DeVries has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many of his projects.

Conclusion: Gerald Woodrow DeVries' passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazing inventor in the world of technology. His dedication to creating solutions that improve the lives of people globally serves as an inspiration to aspiring inventors everywhere.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…